SynthesisClinical & experimental metastasis2024

Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis.

Qiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.